Stem Cells Market And Drug Discovery Applications, 2009-2015

Date: July 22, 2010
Pages: 410
Price:
US$ 3,783.00
License [?]:
Publisher: Axis Research Mind
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: S49DD64AE95EN
Leaflet:

Download PDF Leaflet

Stem Cells Market And Drug Discovery Applications, 2009-2015
The ‘Stem Cells Market and Drug Discovery applications, 2009-2015’ reviews latest Stem Cells market trends with a perceptive to disclose the near-future growth prospects. An in-depth analysis across the geographic regions provides strategic business intelligence for life science and as well as healthcare sector investments. The study offers profitable investment strategies for stem cell banks, stem cells R&D organizations, pharmaceutical manufacturers, biotechnology companies, laboratories, Contract Research Organizations (CROs) and many more in preferred locations. The report primarily focuses on:
  • Latest Market Trends
  • Region-wise Demand Factor
  • Key Growth Areas
  • Market Sizes
  • Key Competitors Edge
  • Investment Strategies

The report delivers a microscopic study of major stem cells product segments and applications of drug discovery in stem cells market, worldwide. The stem cells product segments include adult stem cells, cord blood stem cells, embryonic stem cells and others. The major stem cells drug discovery applications discussed in the report are:
  • Cell Therapy and Regenerative Medicine
  • High-Content Screening Assays and Toxicology
  • Replacement of Damaged Cells

The report centers on major current market trends, estimates and forecasts for the period 2009-2015. More than 500 leading market players are identified and 37 key companies that project improved market activities in the coming years are profiled. The report consists of 253 data charts describing market shares, sales forecasts and growth prospects. Moreover, key strategic activities in the market including mergers/acquisitions, collaborations/partnerships, product launches/developments are discussed which gives a deep insight into the growth perspectives of the market.

The region-wise distribution of the market consists of North America (USA, Canada and Mexico); Europe (Belgium, Denmark, France, Germany, Greece, Spain, Sweden, United Kingdom and Rest of Europe); Asia-Pacific (Australia, China, India, Japan, South Korea and Rest of Asia-Pacific); Latin America (Argentina and Brazil) and Rest of the World (Columbia, Middle East, South Africa and Rest of Rest of World). Incorporating the recession impacts on the industry, the market growth rate in the major economies such as the U.S., Japan and China along with the other emerging countries are estimated individually for the upcoming years. Anticipating a protracted economic recovery towards to 2011 and based on the CAGR estimates and growth potential, we have forecasted the market size figures for the next five years.

Estimates are based on online surveys using customized questionnaires by our research team. Besides information from government databases, company websites, press releases & published research reports are also used for estimates. Estimates have incorporated recessionary impact on the stem cells industry.

GLOBAL MARKET WATCH:

Global stem cells market is forecasts to reach US$63.8 billion by 2015 from an estimated value of US$21.5 billion in 2010, exhibiting a triple fold growth rate during the period 2010-2015. In terms of drug discovery applications using stem cells, North America and Europe account for more than 60% of the market value. However, the largest growth rate during 2009-2015 is expected from Asia-Pacific, a CAGR of 26.5%. China, India, Greece, Spain, Sweden, Germany and the US are at the forefront in driving the sector growth with an annual growth rate of more than 27% during the period. Brazil and Argentina are the Latin American majors in drug discovery applications using stem cells. Stem cells use in replacing damaged cells is expected to witness highest investments in the upcoming years as the CAGR forecasts for the sector is high. Estimates for cell therapy and regenerative medicine market indicate a CAGR of nearly 24% CAGR during 2009-2015.

The stem cell market is expected to witness a substantial growth in the upcoming years, with a CAGR of 24.2%, globally. Although North America will likely post highest market value by 2015, Asian economies are expected to maintain large CAGR of 27 percent during 2010-2015. The higher growth rate indicates improved industry investments in the Asia-Pacific region in comparison with North America and Europe, going ahead.

Improving health consciousness in Europe will likely maintain the stem cell market of the European Union competent with Asia-Pacific/North America. India possesses the potential to occupy the leading position in stem cell market growth with a CAGR exceeding 28 percent through 2015. Spain, Sweden and Germany are anticipated to top among the European countries with an annual compounded growth rate of more than 27 percent respectively through 2010-2015. Latin American countries will not likely experience a massive growth rate in comparison with North American/Asian economies. Overall, emerging economies could tag higher growth rate stem cells market in the next few years.
I. REPORT FOCUS

A. INTRODUCTION

Functions Of Stem Cells
Stem Cell Applications
Stem Cell Milestones
Definition And Importance
Stem Cell Debate
Conclusion

B. STEM CELLS – THE BEGINNING OF ALL BLOOD CELLS

Adult Stem Cells
Embryonic Stem Cells
Umbilical Cord Blood Stem Cells
Totipotent Stem Cells
Pluripotent Stem Cells
Multipotent Stem Cells
Oligopotent Stem Cells
Unipotent Stem Cells
Induced Pluripotent Stem Cells (IPSCS)
Disease Detection
Challenges To Culture
Standard Guideline For IPS Technology

C. ADVANCES IN STEM CELL RESEARCH

D. SIMILARITIES AND DIFFERENCES BETWEEN EMBRYONIC AND ADULT STEM CELLS

E. THE CONTROVERSY ON STEM CELL

Stem Cells Background
Outlook
Argument
Proper Use
Transcendence
The Beginning
Life Importance

F. A REVIEW ON ADULT STEM CELLS

The Role Of Adult Stem Cells In Tissue Repair
Adult Stem Cells And Cancer
First Transplantation Of Human Organ Grown From Adult Stem Cells
Advantages Of Adult Bm Cells Transplantation In Cardiology
Conclusion

G. A REVIEW ON EMBRYONIC STEM CELLS

History
Major Support To Embryonic Stem Cell Research
A Combined Effort
Confusing Legislation
Rewarding The Deserving
Governmental Policy In Different Regions
Americas
United States
Europe
Asia-Pacific
Africa
Embryonic Stem Cell Research “Controversy”
Creation Of Embryonic Characteristics From Human Umbilical Cord Blood
Human Embryonic Stem Cells (Hes) Classification And Differentiation
Origin, Expansion And Applications Of Human Embryonic Stem Cells
Advantages Of Es Cell Transplantation In Cardiology

H. A REVIEW ON CORD BLOOD STEM CELLS

Enhancements
Uses Of Cord Blood Banking
Focus And Scope Of Companies Into Cord Blood Stem Cells
BMSN (Bio-Matrix Scientific Group, INC.)
Medistem INC.
Cryo-Cell International, Inc.
Glance AT U.S Private Family Banks
Cord Blood America, Inc.
Viacell, Inc.
Other Companies
Progress In Cord Blood Collection, Processing And Transplantation
Tight Measures And Certifications
Test On Stem Cells From Blood Cord

I. ROLE OF STEM CELLS IN DRUG DISCOVERY

Stem Cell In Drug Discovery
Embryonic Stem Cells As A Source Of Models For Drug Discovery
Stem Cell In Drug Discovery Trade Implications
Stem Cell Use And Prospect In Drug Innovation
Adult Or Mature Stem Cells
Human Adult Stem Cells To Differentiate Into A Number Of Important Specialized Cell TYPES
Scalability For IVD
Research
Conclusion

II. MARKET ANALYSIS

Stem Cells Market And Drug Discovery Applications – Snapshot
A. STEM CELLS MARKET AND DRUG DISCOVERY APPLICATIONS – SEGMENTATION
B. STEM CELLS – BY COUNTRY
North America
Europe
Asia-Pacific
Latin America
Rest Of World

C. STEM CELLS – PRODUCT SEGMENTS

C1. STEM CELL PRODUCT SEGMENTS - GEOGRAPHIC REGION

ADULT STEM CELLS
North America
Europe
Asia-Pacific
Latin America
Rest Of World

CORD BLOOD STEM CELLS

North America
Europe
Asia-Pacific
Latin America
Rest Of World

EMBRYONIC STEM CELLS

North America
Europe
Asia-Pacific
Latin America
Rest Of World

OTHER STEM CELLS

North America
Europe
Asia-Pacific
Latin America
Rest Of World

C2. STEM CELLS – BY PRODUCT

NORTH AMERICA

The USA
Canada
Mexico

EUROPE

Belgium
Denmark
France
Germany
Greece
Spain
Sweden
The United Kingdom
Rest Of Europe

ASIA-PACIFIC

Australia
China
India
Japan
South Korea
Rest Of Asia-Pacific

LATIN AMERICA

Argentina
Brazil

REST OF WORLD

Columbia
Middle East
South Africa
Rest Of Rest Of The World

D. STEM CELLS IN DRUG DISCOVERY

E. STEM CELLS IN DRUG DISCOVERY – BY COUNTRY


North America
Europe
Asia-Pacific
Latin America
Rest Of World

F. STEM CELLS IN DRUG DISCOVERY – APPLICATIONS

F1. STEM CELLS IN DRUG DISCOVERY – APPLICATIONS - GEOGRAPHIC REGION

CELL THERAPY AND REGENERATIVE MEDICINE


North America
Europe
Asia-Pacific
Latin America
Rest Of World

HIGH-CONTENT SCREENING ASSAYS AND TOXICOLOGY

North America
Europe
Asia-Pacific
Latin America
Rest Of World

REPLACEMENT OF DAMAGED CELLS

North America
Europe
Asia-Pacific
Latin America
Rest Of World

OTHERS

North America
Europe
Asia-Pacific
Latin America
Rest Of World

F2. STEM CELLS IN DRUG DISCOVERY – BY APPLICATION

NORTH AMERICA


The USA
Canada
Mexico

EUROPE

Belgium
Denmark
France
Germany
Greece
Spain
Sweden
United Kingdom
Rest Of World

ASIA-PACIFIC

Australia
China
India
Japan
South Korea
Rest Of Asia-Pacific

LATIN AMERICA

Argentina
Brazil

REST OF WORLD

Columbia
Middle East
South Africa
Rest Of Rest Of World

G. GROWTH RATE ANALYSIS

Global Stem Cells Market And Drug Discovery Applications Market Growth Rates
Stem Cells Market Growth Rates

STEM CELLS - PRODUCT SEGMENTS

Global Stem Cells Product Segments Market Growth Rates
Adult Stem Cells
Cord Blood Stem Cells
Embryonic Stem Cells

STEM CELLS IN DRUG DISCOVERY – APPLICATIONS

Global Stem Cells In Drug Discovery Applications Market Growth Rates
Cell Therapy And Regenerative Medicine
High-Content Screening Assays And Toxicology
Replacement Of Damaged Cells

H. INVESTMENT FOCUS

III. INDUSTRY OVERVIEW

A. INDUSTRY ACTIVITIES

Mergers/Acquisitions/Agreements/Patents Grants/Joint Ventures/Etc……
New Culture Dish Overcomes The Limitations In Human Embryonic Stem Cell Research
Stem Cell Therapy A Major Role For Acute Lung Damage In Mice
New Approach In Medical Application Of Resourceful And Protected Pluripotent
Stem Cells For Engendering
Regenerative Stem Cell Treatments With Patients Having Congestive
Heart Failure Bioheart Therapies
Stem Cell Modulator Pipeline With Acquisition Of Fate Therapeutics
With Verio Therapeutics
SRU Biosystems Announces Introduction Of Bind(R) Scanner For Primary And
Stem Cell Applications
New Progress Directed To A Get Through Process For Extended
Medical Application Of Mature Stem Cells
Agreement For Patent And Cultivation Of Pluripotent Stem Cells
Application On Chemokine Technology To Increase Efficacy Of Tissue-Specific
Stem Cell Homing In Copd Treatment
Testing Of Retinal Pigment From Human Parthenogenetic Stem Cells
Augmentation Feature Help Stem Cell Growth: Regeneration
Adult Allogeneic Mesenchymal Stem Cells Treatment For Stroke From
Stemedica Cell Technologies, INC.
Stem Cell Manufacturing For Stroke And Clinical Trial From Reneuron Group PLC
Patent Grand For Pluripotent Rat Stem Cells And Genetically Engineered
Rats For Stemcells, INC.
Stem Cells Build New Blood Vessels For The Treatment Peripheral Arterial Disease
Stem Cells Employed In Treatment Of Peripheral Arterial Disease
Proprietary Adult Stem Cell Lines Formation
The Synthemax(Tm) Surface For Scalable Growth Of Human Embryo Developed By
Geron Corporation And Corning Incorporated
Stem Cell Innovations To Offer Agennix The Research And Assay Services.
Cardiac Stem Cell Therapy Presentation - Bmt Tandem Meet By Osiris Therapeutics
Stem Cell Therapy For Cardiac Diseases
Effective Use Of Proprietary Stem Cells In The Treatment Of Cirrhosis Of The Liver
Regenocyte Effectively Cures Cardiomyopathy Patient Using Individual
Adult Stem Cells
Limbs With Peripheral Arterial Disease Can Be Saved By Using Adult Stem Cells
Gamida Cell ltd. Continuation Of Research On Stemex(r), A Cord Blood
Stem Cell Product, For Leukemia And Lymphoma
Bioheart’s Innovation Of First Fda Grant Clinical Trial To Test Congestive
Heart Failure For Gene-Modified Stem Cell Therapy
Fate Therapeutics Gets Grant Of First U.S. Copyright For Induced
Pluripotent Stem Cell Expertise
Stem Cells In Drug Discovery And Development
Stem Cell Therapy International Corp. Completely Amalgamated
With Histostem, CO., LTD.
Cancer Stem Cell Theories
Lost Vision Restored - Thanks To Umbilical Stem Cell Therapies
India The Next Potential Stem Cell Market – Cordlife
Regenerative Medicine Gets A Backup With Stem Cell Technology
Romania Starts Its Earliest Stem Cell Friendly Case
New Cord Blood Therapy! A New Ray Of Hope For Many Thalassemia Affected Patients.
Florida University Scientists Discover That Blood Stem Cells Can Be
Changed To Visualization Cells
Dissimilarity Established Between Embryonic Stem Cells And Reprogrammed Skin Cells
Applications Invited For Post-Doc In Stem Cell Biology
(Molecular Biology/Cell Biology) In Bonn
“Bush’s Stem Cell Restrictions To Go” Says President Obama
Obama To Lift The Ban Imposed By Bush On Embryonic Stem Cell Research
Initial Stem Cell Test Granted By FDA
Enhanced Blood Transfusion Supplies With Advent Of Stem Cells
Stem Cells Being Used To Perform Efficiency And Toxicity Screening Of Compounds

B. MARKET TRENDS

Stem Cell Treatment To Cure Diabetes
Revolutionary Stem Cell Remedy Reinstates Sight
Ucla Study Reveals The Use Of Stem Cells To Destroy HIV
Stem Cells Capable Of Assisting Angina Patients
Agreement Sketching Out Moral Approach To Stem Cell Planned
Hottest Developments In Stem Cells Treatments
Embryonic Stem Cells Study Being Turned Into A Contentious Discussion
Adult Stem Cells Growing To Be A Hopeful Market
Human Experimental Test Of Stem Cell Based Medicine
Stem Cells Capable Of Reinstating Misplaced Brain Tasks
Growing Heart Valves From Stem Cells
Stem Cell Treatment Could Possibly Work In Opposition To Brain Inflammation
Resourceful Stem Cells Discovered In Amniotic Fluid
Stem Cell Progress Being Hit By Traditionalist

C. INDUSTRY LEADERS

Aastrom Biosciences, Inc.
Advanced Cell Technology, Inc.
Bioheart, Inc.
Cell Therapeutics, Inc.
Sigma-Aldrich, Co.
Stem Cell Innovations, Inc.
Viacord
Cells4life, Ltd.
Sanofi Aventis
Cryocord SDN. BHD.

D. STEM CELLS AND TECHNOLOGIES – A LOOK A HEAD..!!

E. KEY COMPANY PROFILES


North America
Europe
Asia-Pacific

V. APPENDIX

A. Research Focus
B. About Axis Research Mind
C. Disclaimer
D. Feedback

LIST OF TABLES/CHARTS

I. REPORT FOCUS

1. Stem Cells Product Categories Chosen In The Report
2. Differential Potential Ranges From Totipotent Stem Cells To Nullipotent Cells
3. Stem Cells Banking Storage Price Structure Around The World
4. Stem Cells Companies In Different Countries With Their Number Of Transplants

II. MARKET ANALYSIS

A. STEM CELLS

5. Global Stem Cells - Segmentation By Products & By Drug Discovery Applications
6. Stem Cells - Global Current Trends, Estimates & Forecasts - (2009-2015, in USD$ Million)
7. Stem Cells - Geographic Region Current Trends, Estimates & Forecasts For North America, Europe, Asia-Pacific, Latin America And Rest Of World - (2009-2015, in USD$ Million)
8. Stem Cells - % Of North America, Europe, Asia-Pacific, Latin America And Rest Of World Market Value - (2009 - 2012 - 2015)

B. STEM CELLS – BY COUNTRY

9. Stem Cells - Usa, Canada And Mexico - (2009-2015, in USD$ Million)
10. Stem Cells - % Of Usa, Canada And Mexico Market Value - (2009 - 2012 - 2015)
11. Stem Cells - Belgium, Denmark, France, Germany, Greece, Spain, Sweden, United Kingdom And Rest Of Europe - (2009-2015, in USD$ Million)
12. Stem Cells - % Of Belgium, Denmark, France, Germany, Greece, Spain, Sweden, United Kingdom And Rest Of Europe Market Value - (2009 - 2012 - 2015)
13. Stem Cells - Australia, China, India, Japan, South Korea And Rest Of Asia-Pacific - (2009-2015, in USD$ Million)
14. Stem Cells - % Of Australia, China, India, Japan, South Korea And Rest Of Asia-Pacific Market Value - (2009 - 2012 - 2015)
15. Stem Cells - Argentina And Brazil - (2009-2015, in USD$ Million)
16. Stem Cells - % Of Argentina And Brazil Market Value - (2009 - 2012 - 2015)
17. Stem Cells - Columbia, Middle East, South Africa And Rest Of Rest Of World - (2009-2015, in USD$ Million)
18. Stem Cells - Columbia, Middle East, South Africa And Rest Of Rest Of World - % Of Rest Of World Market Value - (2009 - 2012 - 2015)

C. STEM CELLS – PRODUCT SEGMENTS

19. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells And Others For Global Current Trends, Estimates & Forecasts - (2009-2015, in USD$ Million)
20. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells And Others - % Of Global Market Value - (2009 - 2012 - 2015)

ADULT STEM CELLS

21. Stem Cell Products - Adult Stem Cells By Geographic Region Current Trends, Estimates & Forecasts For North America, Europe, Asia-Pacific, Latin America And Rest Of World - (2009-2015, in USD$ Million)
22. Stem Cell Products - Adult Stem Cells - % Of North America, Europe, Asia-Pacific, Latin America And Rest Of World Market Value By Geographic Region - (2009 - 2012 - 2015)
23. Stem Cell Products - Adult Stem Cells For Usa, Canada And Mexico - (2009-2015, in USD$ Million)
24. Stem Cell Products - Adult Stem Cells - % Of Usa, Canada And Mexico Market Value - (2009 - 2012 - 2015)
25. Stem Cell Products - Adult Stem Cells For Denmark, France, Germany, Spain, Sweden, United Kingdom And Rest Of Europe - (2009-2015, in USD$ Million)
26. Stem Cell Products - Adult Stem Cells - % Of Denmark, France, Germany, Spain, Sweden, United Kingdom And Rest Of Europe Market Value - (2009 - 2012 - 2015)
27. Stem Cell Products - Adult Stem Cells For Australia, China, India, Japan, South Korea And Rest Of Asia-Pacific - (2009-2015, in USD$ Million)
28. Stem Cell Products - Adult Stem Cells - % Of Australia, China, India, Japan, South Korea And Rest Of Asia-Pacific Market Value - (2009 - 2012 - 2015)
29. Stem Cell Products - Adult Stem Cells For Argentina And Brazil - (2009-2015, in USD$ Million)
30. Stem Cell Products - Adult Stem Cells - % Of Argentina And Brazil Market Value - (2009 - 2012 - 2015)
31. Stem Cell Products - Adult Stem Cells For Columbia, Middle East, South Africa And Rest Of Rest Of World - (2009-2015, in USD$ Million)
32. Stem Cell Products - Adult Stem Cells - % Of Columbia, Middle East, South Africa And Rest Of Rest Of World Market Value - (2009 - 2012 - 2015)

CORD BLOOD STEM CELLS

33. Stem Cell Products - Cord Blood Stem Cells By Geographic Region Current Trends, Estimates & Forecasts For North America, Europe, Asia-Pacific, Latin America And Rest Of World - (2009-2015, in USD$ Million)
34. Stem Cell Products - Cord Blood Stem Cells - % Of North America, Europe, Asia-Pacific, Latin America And Rest Of World Market Value By Geographic Region - (2009 - 2012 - 2015)
35. Stem Cell Products - Cord Blood Stem Cells For Usa, Canada And Mexico - (2009-2015, in USD$ Million)
36. Stem Cell Products - Cord Blood Stem Cells - % Of Usa, Canada And Mexico Market Value - (2009 - 2012 - 2015)
37. Stem Cell Products - Cord Blood Stem Cells For Denmark, France, Germany, Spain, Sweden, United Kingdom And Rest Of Europe - (2009-2015, in USD$ Million)
38. Stem Cell Products - Cord Blood Stem Cells - % Of Denmark, France, Germany, Spain, Sweden, United Kingdom And Rest Of Europe Market Value - (2009 - 2012 - 2015)
39. Stem Cell Products - Cord Blood Stem Cells For Australia, China, India, Japan, South Korea And Rest Of Asia-Pacific - (2009-2015, in USD$ Million)
40. Stem Cell Products - Cord Blood Stem Cells - % Of Australia, China, India, Japan, South Korea And Rest Of Asia-Pacific Market Value - (2009 - 2012 - 2015)
41. Stem Cell Products - Cord Blood Stem Cells For Argentina And Brazil - (2009-2015, in USD$ Million)
42. Stem Cell Products - Cord Blood Stem Cells - % Of Argentina And Brazil Market Value - (2009 - 2012 - 2015)
43. Stem Cell Products - Cord Blood Stem Cells For Columbia, Middle East, South Africa And Rest Of Rest Of World - (2009-2015, in USD$ Million)
44. Stem Cell Products - Cord Blood Stem Cells - % Of Columbia, Middle East, South Africa And Rest Of Rest Of World Market Value - (2009 - 2012 - 2015)

EMBRYONIC STEM CELLS

45. Stem Cell Products - Embryonic Stem Cells By Geographic Region Current Trends, Estimates & Forecasts For North America, Europe, Asia-Pacific, Latin America And Rest Of WORLD - (2009-2015, in USD$ Million)
46. Stem Cell Products - Embryonic Stem Cells - % Of North America, Europe, Asia-Pacific, Latin America And Rest Of World Market Value By Geographic Region - (2009 - 2012 - 2015)
47. Stem Cell Products - Embryonic Stem Cells For Usa And Canada - (2009-2015, in USD$ Million)
48. Stem Cell Products - Embryonic Stem Cells - % Of Usa And Canada Market Value - (2009 - 2012 - 2015)
49. Stem Cell Products - Embryonic Stem Cells For Belgium, Denmark, France, Greece, Spain, Sweden, United Kingdom And Rest Of Europe - (2009-2015, in USD$ Million)
50. Stem Cell Products - Embryonic Stem Cells - % Of Belgium, Denmark, France, Greece, Spain, Sweden, United Kingdom And Rest Of Europe Market Value - (2009 - 2012 - 2015)
51. Stem Cell Products - Embryonic Stem Cells For Australia, China, India, Japan, South Korea And Rest Of Asia-Pacific - (2009-2015, in USD$ Million)
52. Stem Cell Products - Embryonic Stem Cells - % Of Australia, China, India, Japan, South Korea And Rest Of Asia-Pacific Market Value - (2009 - 2012 - 2015)
53. Stem Cell Products - Embryonic Stem Cells For Brazil - (2009-2015, in USD$ Million)
54. Stem Cell Products - Embryonic Stem Cells For Middle East, South Africa And Rest Of Rest Of World - (2009-2015, in USD$ Million)
55. Stem Cell Products - Embryonic Stem Cells - % Of Middle East, South Africa And Rest Of Rest Of World Market Value - (2009 - 2012 - 2015)

OTHER STEM CELLS

56. Stem Cell Products - Other Stem Cells By Geographic Region Current Trends, Estimates & Forecasts For North America, Europe, Asia-Pacific, Latin America And Rest Of World - (2009-2015, in USD$ Million)
57. Stem Cell Products - Other Stem Cells - % Of North America, Europe, Asia-Pacific, Latin America And Rest Of World Market Value By Geographic Region - (2009 - 2012 - 2015)
58. Stem Cell Products - Other Stem Cells For Usa, Canada And Mexico - (2009-2015, in USD$ Million)
59. Stem Cell Products - Other Stem Cells - % Of Usa, Canada And Mexico Market VALUE - (2009 - 2012 - 2015)
60. Stem Cell Products - Other Stem Cells For Denmark, France, Germany, Spain, Sweden, United Kingdom And Rest Of Europe - (2009-2015, in USD$ Million)
61. Stem Cell Products - Other Stem Cells - % Of Denmark, France, Germany, Spain, Sweden, United Kingdom And Rest Of Europe Market Value - (2009 - 2012 - 2015)
62. Stem Cell Products - Other Stem Cells For Australia, China, India, Japan, South Korea And Rest Of Asia-Pacific - (2009-2015, in USD$ Million)
63. Stem Cell Products - Other Stem Cells - % Of Australia, China, India, Japan, South Korea And Rest Of Asia-Pacific Market Value - (2009 - 2012 - 2015)
64. Stem Cell Products - Other Stem Cells For Argentina And Brazil - (2009-2015, in USD$ Million)
65. Stem Cell Products - Other Stem Cells - % Of Argentina And Brazil Market Value - (2009 - 2012 - 2015)
66. Stem Cell Products - Other Stem Cells For Columbia, Middle East, South Africa And Rest Of Rest Of World - (2009-2015, in USD$ Million)
67. Stem Cell Products - Other Stem Cells - % Of Columbia, Middle East, South Africa And Rest Of Rest Of World Market Value - (2009 - 2012 - 2015)

C2. STEM CELLS – BY PRODUCT

NORTH AMERICA

68. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells And Others For North America - (2009-2015, in USD$ Million)
69. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells And Others - % Of North American Market Value - (2009 - 2012 - 2015)
70. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells And Others For The United States Of America - (2009-2015, in USD$ Million)
71. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells And Others - % Of The United States Of America Market Value - (2009 - 2012 - 2015)
72. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells And Others For Canada - (2009-2015, in USD$ Million)
73. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells And Others - % Of Canadian Market Value - (2009 - 2012 - 2015)
74. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, And Others For MEXICO - (2009-2015, in USD$ Million)
75. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells And Others - % Of Mexican Market Value - (2009 - 2012 - 2015)

EUROPE

76. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells And Others For Europe - (2009-2015, in USD$ Million)
77. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells And Others - % Of European Market Value - (2009 - 2012 - 2015)
78. Stem Cell Products - Embryonic Stem Cells For Belgium - (2009-2015, in USD$ Million)
79. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells And Others For Denmark - (2009-2015, in USD$ Million)
80. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells And Others - % Of Danish Market Value - (2009 - 2012 - 2015)
81. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells And Others For France - (2009-2015, in USD$ Million)
82. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells And Others - % Of French Market Value - (2009 - 2012 - 2015)
83. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, And Others For Germany - (2009-2015, in USD$ Million)
84. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells And Others - % Of German Market Value - (2009 - 2012 - 2015)
85. Stem Cell Products - Embryonic Stem Cells For Greece - (2009-2015, in USD$ Million)
86. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells And Others For Spain - (2009-2015, in USD$ Million)
87. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells And Others - % Of Spanish Market Value - (2009 - 2012 - 2015)
88. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells And Others For Sweden - (2009-2015, in USD$ Million)
89. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells And Others - % Of Swedish Market Value - (2009 - 2012 - 2015)
90. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells And Others For The United Kingdom - (2009-2015, in USD$ Million)
91. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells And Others - % Of The United Kingdom Market Value - (2009 - 2012 - 2015)
92. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells And Others For Rest Of Europe - (2009-2015, in USD$ Million)
93. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells And Others - % Of Rest Of Europe Market Value - (2009 - 2012 - 2015)

ASIA-PACIFIC

94. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells And Others For Asia-Pacifc - (2009-2015, in USD$ Million)
95. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells And Others - % Of Asia-Pacific Market Value - (2009 - 2012 - 2015)
96. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells And Others For Australia - (2009-2015, in USD$ Million)
97. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells And Others - % Of Australian Market Value - (2009 - 2012 - 2015)
98. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells And Others For China - (2009-2015, in USD$ Million)
99. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells And Others - % Of Chinese Market Value - (2009 - 2012 - 2015)
100. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells And Others For India - (2009-2015, in USD$ Million)
101. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells And Others - % Of Indian Market Value - (2009 - 2012 - 2015)
102. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells And Others For Japan - (2009-2015, in USD$ Million)
103. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells And Others - % Of Japanese Market Value - (2009 - 2012 - 2015)
104. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells And Others For South Korea - (2009-2015, in USD$ Million)
105. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells And Others - % Of South Korean Market Value - (2009 - 2012 - 2015)
106. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells And Others For Rest Of Asia-Pacific - (2009-2015, in USD$ Million)
107. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells And Others - % Of Rest Of Asia-Pacific Market Value - (2009 - 2012 - 2015)

LATIN AMERICA

108. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells And Others For Latin America - (2009-2015, in USD$ Million)
109. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells And Others - % Of Latin American Market Value - (2009 - 2012 - 2015)
110. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, And Others For Argentina - (2009-2015, in USD$ Million)
111. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, And Others - % Of Argentina Market Value - (2009 - 2012 - 2015)
112. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells And Others For Brazil - (2009-2015, in USD$ Million)
113. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells And Others - % Of Brazilian Market Value - (2009 - 2012 - 2015)

REST OF WORLD

114. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells And Others For Rest Of World - (2009-2015, in USD$ Million)
115. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells And Others - % Of Rest Of World Market Value - (2009 - 2012 - 2015)
116. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells And Others For Columbia - (2009-2015, in USD$ Million)
117. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells And Others - % Of Columbian Market Value - (2009 - 2012 - 2015)
118. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells And Others For Middle East - (2009-2015, in USD$ Million)
119. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells And Others - % Of Middle East Market Value - (2009 - 2012 - 2015)
120. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells And Others For South Africa - (2009-2015, in USD$ Million)
121. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells And Others - % Of South African Market Value - (2009 - 2012 - 2015)
122. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells And Others For Rest Of Rest Of World - (2009-2015, in USD$ Million)
123. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells And Others - % Of Rest Of Rest Of World Market Value - (2009 - 2012 - 2015)

D. STEM CELLS IN DRUG DISCOVERY

124. Stem Cells In Drug Discovery - Global Current Trends, Estimates & Forecasts - (2009-2015, in USD$ Million)
125. Stem Cells In Drug Discovery - Geographic Region Current Trends, Estimates & Forecasts For North America, Europe, Asia-Pacific, Latin America And Rest Of World - (2009-2015, in USD$ Million)
126. Stem Cells In Drug Discovery - % Of North America, Europe, Asia-Pacific, Latin America And Rest Of World Market Value - (2009 - 2012 - 2015)

E. STEM CELLS IN DRUG DISCOVERY – BY COUNTRY

127. Stem Cells In Drug Discovery - Usa, Canada And Mexico - (2009-2015, in USD$ Million)
128. Stem Cells In Drug Discovery - % Of Usa, Canada And Mexico Market Value - (2009 - 2012 - 2015)
129. Stem Cells In Drug Discovery - Belgium, Denmark, France, Germany, Greece, Spain, Sweden, United Kingdom And Rest Of Europe - (2009-2015, in USD$ Million)
130. Stem Cells In Drug Discovery - % Of Belgium, Denmark, France, Germany, Greece, Spain, Sweden, United Kingdom And Rest Of Europe Market Value - (2009 - 2012 - 2015)
131. Stem Cells In Drug Discovery - Australia, China, India, Japan, South Korea And Rest Of Asia-Pacific - (2009-2015, in USD$ Million)
132. Stem Cells In Drug Discovery - % Of Australia, China, India, Japan, South Korea And Rest Of Asia-Pacific Market Value - (2009 - 2012 - 2015)
133. Stem Cells In Drug Discovery - Argentina And Brazil - (2009-2015, in USD$ Million)
134. Stem Cells In Drug Discovery - % Of Argentina And Brazil Market Value - (2009 - 2012 - 2015)
135. Stem Cells In Drug Discovery - Columbia, Middle East, South Africa And Rest Of Rest Of World - (2009-2015, in USD$ Million)
136. Stem Cells In Drug Discovery - Columbia, Middle East, South Africa And Rest Of Rest Of World - % Of Rest Of World Market Value - (2009 - 2012 - 2015)

F. STEM CELLS IN DRUG DISCOVERY – APPLICATIONS

137. Stem Cells In Drug Discovery Applications - Cell Therapy And Regenerative Medicine, High-Content Screening Assays And Toxicology, Replacement Of Damaged Cells And Others For Global Current Trends, Estimates & Forecasts - (2009-2015, in USD$ Million)
138. Stem Cells In Drug Discovery Applications - Cell Therapy And Regenerative Medicine, High-Content Screening Assays And Toxicology, Replacement Of Damaged Cells And Others - % Of Global Market Value - (2009 - 2012 - 2015)

CELL THERAPY AND REGENERATIVE MEDICINE

139. Stem Cells In Drug Discovery Applications - Cell Therapy And Regenerative Medicine By Geographic Region Current Trends, Estimates & Forecasts For North America, Europe, Asia-Pacific, Latin America And Rest Of World - (2009-2015, in USD$ Million)
140. Stem Cells In Drug Discovery Applications - Cell Therapy And Regenerative Medicine - % Of North America, Europe, Asia-Pacific, Latin America And Rest Of World Market Value By Geographic Region - (2009 - 2012 - 2015)
141. Stem Cells In Drug Discovery Applications - Cell Therapy And Regenerative Medicine For Usa, Canada And Mexico - (2009-2015, in USD$ Million)
142. Stem Cells In Drug Discovery Applications - Cell Therapy And Regenerative Medicine - % Of Usa, Canada And Mexico Market Value - (2009 - 2012 - 2015)
143. Stem Cells In Drug Discovery Applications - Cell Therapy And Regenerative Medicine For Belgium, Denmark, France, Germany, Greece, Spain, Sweden, United Kingdom And Rest Of Europe - (2009-2015, in USD$ Million)
144. Stem Cells In Drug Discovery Applications - Cell Therapy And Regenerative Medicine - % Of Belgium, Denmark, France, Germany, Greece, Spain, Sweden, United Kingdom And Rest Of Europe Market Value - (2009 - 2012 - 2015)
145. Stem Cells In Drug Discovery Applications - Cell Therapy And Regenerative Medicine For Australia, China, India, Japan, South Korea And Rest Of Asia-Pacific - (2009-2015, in USD$ Million)
146. Stem Cells In Drug Discovery Applications - Cell Therapy And Regenerative Medicine - % Of Australia, China, India, Japan, South Korea And Rest Of Asia-Pacific Market Value - (2009 - 2012 - 2015)
147. Stem Cells In Drug Discovery Applications - Cell Therapy And Regenerative Medicine For Argentina And Brazil - (2009-2015, in USD$ Million)
148. Stem Cells In Drug Discovery Applications - Cell Therapy And Regenerative Medicine - % Of Argentina And Brazil Market Value - (2009 - 2012 - 2015)
149. Stem Cells In Drug Discovery Applications - Cell Therapy And Regenerative Medicine For Columbia, Middle East, South Africa And Rest Of Rest Of World - (2009-2015, in USD$ Million)
150. Stem Cells In Drug Discovery Applications - Cell Therapy And Regenerative Medicine - % Of Columbia, Middle East, South Africa And Rest Of Rest Of World Market Value - (2009 - 2012 - 2015)

HIGH-CONTENT SCREENING ASSAYS AND TOXICOLOGY

151. Stem Cells In Drug Discovery Applications - High-Content Screening Assays And Toxicology By Geographic Region Current Trends, Estimates & Forecasts For North America, Europe, Asia-Pacific, Latin America And Rest Of World - (2009-2015, in USD$ Million)
152. Stem Cells In Drug Discovery Applications - High-Content Screening Assays And Toxicology - % Of North America, Europe, Asia-Pacific, Latin America And Rest Of World Market Value By Geographic Region - (2009 - 2012 - 2015)
153. Stem Cells In Drug Discovery Applications - High-Content Screening Assays And Toxicology For Usa, Canada And Mexico - (2009-2015, in USD$ Million)
154. Stem Cells In Drug Discovery Applications - High-Content Screening Assays And Toxicology - % Of Usa, Canada And Mexico Market Value - (2009 - 2012 - 2015)
155. Stem Cells In Drug Discovery Applications - High-Content Screening Assays And Toxicology For Belgium, Denmark, France, Germany, Greece, Spain, Sweden, United Kingdom And Rest Of Europe - (2009-2015, in USD$ Million)
156. Stem Cells In Drug Discovery Applications - High-Content Screening Assays And Toxicology - % Of Belgium, Denmark, France, Germany, Greece, Spain, Sweden, United Kingdom And Rest Of Europe Market Value - (2009 - 2012 - 2015)
157. Stem Cells In Drug Discovery Applications - High-Content Screening Assays And Toxicology For Australia, China, India, Japan, South Korea And Rest Of Asia-Pacific - (2009-2015, in USD$ Million)
158. Stem Cells In Drug Discovery Applications - High-Content Screening Assays And Toxicology - % Of Australia, China, India, Japan, South Korea And Rest Of Asia-Pacific Market Value - (2009 - 2012 - 2015)
159. Stem Cells In Drug Discovery Applications - High-Content Screening Assays And Toxicology For Argentina And Brazil - (2009-2015, in USD$ Million)
160. Stem Cells In Drug Discovery Applications - High-Content Screening Assays And Toxicology - % Of Argentina And Brazil Market Value - (2009 - 2012 - 2015)
161. Stem Cells In Drug Discovery Applications - High-Content Screening Assays And Toxicology For Columbia, Middle East, South Africa And Rest Of Rest Of World - (2009-2015, in USD$ Million)
162. Stem Cells In Drug Discovery Applications - High-Content Screening Assays And Toxicology - % Of Columbia, Middle East, South Africa And Rest Of Rest Of World Market Value - (2009 - 2012 - 2015)

REPLACEMENT OF DAMAGED CELLS

163. Stem Cells In Drug Discovery Applications - Replacement Of Damaged Cells By Geographic Region Current Trends, Estimates & Forecasts For North America, Europe, Asia-Pacific, Latin America And Rest Of World - (2009-2015, in USD$ Million)
164. Stem Cells In Drug Discovery Applications - Replacement Of Damaged Cells - % Of North America, Europe, Asia-Pacific, Latin America And Rest Of World Market Value By Geographic Region - (2009 - 2012 - 2015)
165. Stem Cells In Drug Discovery Applications - Replacement Of Damaged Cells For Usa, Canada And Mexico - (2009-2015, in USD$ Million)
166. Stem Cells In Drug Discovery Applications - Replacement Of Damaged Cells - % Of Usa, Canada And Mexico Market Value - (2009 - 2012 - 2015)
167. Stem Cells In Drug Discovery Applications - Replacement Of Damaged Cells For Belgium, Denmark, France, Germany, Greece, Spain, Sweden, United Kingdom And Rest Of Europe - (2009-2015, in USD$ Million)
168. Stem Cells In Drug Discovery Applications - Replacement Of Damaged Cells - % Of Belgium, Denmark, France, Germany, Greece, Spain, Sweden, United Kingdom And Rest Of Europe Market Value - (2009 - 2012 - 2015)
169. Stem Cells In Drug Discovery Applications - Replacement Of Damaged Cells For Australia, China, India, Japan, South Korea And Rest Of Asia-Pacific - (2009-2015, in USD$ Million)
170. Stem Cells In Drug Discovery Applications - Replacement Of Damaged Cells - % Of Australia, China, India, Japan, South Korea And Rest Of Asia-Pacific Market Value - (2009 - 2012 - 2015)
171. Stem Cells In Drug Discovery Applications - Replacement Of Damaged Cells For Argentina And Brazil - (2009-2015, in USD$ Million)
172. Stem Cells In Drug Discovery Applications - Replacement Of Damaged Cells - % Of Argentina And Brazil Market Value - (2009 - 2012 - 2015)
173. Stem Cells In Drug Discovery Applications - Replacement Of Damaged Cells For Columbia, Middle East, South Africa And Rest Of Rest Of World - (2009-2015, in USD$ Million)
174. Stem Cells In Drug Discovery Applications - Replacement Of Damaged Cells - % Of Columbia, Middle East, South Africa And Rest Of Rest Of World Market Value - (2009 - 2012 - 2015)

OTHERS

175. Stem Cells In Drug Discovery Applications - Others By Geographic Region Current Trends, Estimates & Forecasts For North America, Europe, Asia-Pacific, Latin America And Rest Of World - (2009-2015, in USD$ Million)
176. Stem Cells In Drug Discovery Applications - Others - % Of North America, Europe, Asia-Pacific, Latin America And Rest Of World Market Value By Geographic Region - (2009 - 2012 - 2015)
177. Stem Cells In Drug Discovery Applications - Others For Usa, Canada And Mexico - (2009-2015, in USD$ Million)
178. Stem Cells In Drug Discovery Applications - Others - % Of Usa, Canada And Mexico Market Value - (2009 - 2012 - 2015)
179. Stem Cells In Drug Discovery Applications - Others For Belgium, Denmark, France, Germany, Greece, Spain, Sweden, United Kingdom And Rest Of Europe - (2009-2015, in USD$ Million)
180. Stem Cells In Drug Discovery Applications - Others - % Of Belgium, Denmark, France, Germany, Greece, Spain, Sweden, United Kingdom And Rest Of Europe Market Value - (2009 - 2012 - 2015)
181. Stem Cells In Drug Discovery Applications - Others For Australia, China, India, Japan, South Korea And Rest Of Asia-Pacific - (2009-2015, in USD$ Million)
182. Stem Cells In Drug Discovery Applications - Others - % Of Australia, China, India, Japan, South Korea And Rest Of Asia-Pacific Market Value - (2009 - 2012 - 2015)
183. Stem Cells In Drug Discovery Applications - Others For Argentina And Brazil - (2009-2015, in USD$ Million)
184. Stem Cells In Drug Discovery Applications - Others - % Of Argentina And Brazil Market Value - (2009 - 2012 - 2015)
185. Stem Cells In Drug Discovery Applications - Others For Columbia, Middle East, South Africa And Rest Of Rest Of World - (2009-2015, in USD$ Million)
186. Stem Cells In Drug Discovery Applications - Others - % Of Columbia, Middle East, South Africa And Rest Of Rest Of World Market Value - (2009 - 2012 - 2015)

F2. STEM CELLS IN DRUG DISCOVERY – BY APPLICATION

NORTH AMERICA


187. Stem Cells In Drug Discovery Applications - Cell Therapy And Regenerative Medicine, High-Content Screening Assays And Toxicology, Replacement Of Damaged Cells And Others For North America - (2009-2015, in USD$ Million)
188. Stem Cells In Drug Discovery Applications - Cell Therapy And Regenerative Medicine, High-Content Screening Assays And Toxicology, Replacement Of Damaged Cells And Others - % Of North American Market Value - (2009 - 2012 - 2015)
189. Stem Cells In Drug Discovery Applications - Cell Therapy And Regenerative Medicine, High-Content Screening Assays And Toxicology, Replacement Of Damaged Cells And Others For The Usa - (2009-2015, in USD$ Million)
190. Stem Cells In Drug Discovery Applications - Cell Therapy And Regenerative Medicine, High-Content Screening Assays And Toxicology, Replacement Of Damaged Cells And Others - % Of The Usa Market Value - (2009 - 2012 - 2015)
191. Stem Cells In Drug Discovery Applications - Cell Therapy And Regenerative Medicine, High-Content Screening Assays And Toxicology, Replacement Of Damaged Cells And Others For Canada - (2009-2015, in USD$ Million)
192. Stem Cells In Drug Discovery Applications - Cell Therapy And Regenerative Medicine, High-Content Screening Assays And Toxicology, Replacement Of Damaged Cells And Others - % Of Canadian Market Value - (2009 - 2012 - 2015)
193. Stem Cells In Drug Discovery Applications - Cell Therapy And Regenerative Medicine, High-Content Screening Assays And Toxicology, Replacement Of Damaged Cells And Others For Mexico - (2009-2015, in USD$ Million)
194. Stem Cells In Drug Discovery Applications - Cell Therapy And Regenerative Medicine, High-Content Screening Assays And Toxicology, Replacement Of Damaged Cells And Others - % Of Mexican Market Value - (2009 - 2012 - 2015)

EUROPE

195. Stem Cells In Drug Discovery Applications - Cell Therapy And Regenerative Medicine, High-Content Screening Assays And Toxicology, Replacement Of Damaged Cells And Others For Europe - (2009-2015, in USD$ Million)
196. Stem Cells In Drug Discovery Applications - Cell Therapy And Regenerative Medicine, High-Content Screening Assays And Toxicology, Replacement Of Damaged Cells And Others - % Of European Market Value - (2009 - 2012 - 2015)
197. Stem Cells In Drug Discovery Applications - Cell Therapy And Regenerative Medicine, High-Content Screening Assays And Toxicology, Replacement Of Damaged Cells And Others For Belgium - (2009-2015, in USD$ Million)
198. Stem Cells In Drug Discovery Applications - Cell Therapy And Regenerative Medicine, High-Content Screening Assays And Toxicology, Replacement Of Damaged Cells And Others - % Of Belgium Market Value - (2009 - 2012 - 2015)
199. Stem Cells In Drug Discovery Applications - Cell Therapy And Regenerative Medicine, High-Content Screening Assays And Toxicology, Replacement Of Damaged Cells And Others For Denmark - (2009-2015, in USD$ Million)
200. Stem Cells In Drug Discovery Applications - Cell Therapy And Regenerative Medicine, High-Content Screening Assays And Toxicology, Replacement Of Damaged Cells And Others - % Of Danish Market Value - (2009 - 2012 - 2015)
201. Stem Cells In Drug Discovery Applications - Cell Therapy And Regenerative Medicine, High-Content Screening Assays And Toxicology, Replacement Of Damaged Cells And Others For France - (2009-2015, in USD$ Million)
202. Stem Cells In Drug Discovery Applications - Cell Therapy And Regenerative Medicine, High-Content Screening Assays And Toxicology, Replacement Of Damaged Cells And Others - % Of French Market Value - (2009 - 2012 - 2015)
203. Stem Cells In Drug Discovery Applications - Cell Therapy And Regenerative Medicine, High-Content Screening Assays And Toxicology, Replacement Of Damaged Cells And Others For Germany - (2009-2015, in USD$ Million)
204. Stem Cells In Drug Discovery Applications - Cell Therapy And Regenerative Medicine, High-Content Screening Assays And Toxicology, Replacement Of Damaged Cells And Others - % Of German Market Value - (2009 - 2012 - 2015)
205. Stem Cells In Drug Discovery Applications - Cell Therapy And Regenerative Medicine, High-Content Screening Assays And Toxicology, Replacement Of Damaged Cells And Others For Greece - (2009-2015, in USD$ Million)
206. Stem Cells In Drug Discovery Applications - Cell Therapy And Regenerative Medicine, High-Content Screening Assays And Toxicology, Replacement Of Damaged Cells And Others - % Of Greece Market Value - (2009 - 2012 - 2015)
207. Stem Cells In Drug Discovery Applications - Cell Therapy And Regenerative Medicine, High-Content Screening Assays And Toxicology, Replacement Of Damaged Cells And Others For Spain - (2009-2015, in USD$ Million)
208. Stem Cells In Drug Discovery Applications - Cell Therapy And Regenerative Medicine, High-Content Screening Assays And Toxicology, Replacement Of Damaged Cells And Others - % Of Spanish Market Value - (2009 - 2012 - 2015)
209. Stem Cells In Drug Discovery Applications - Cell Therapy And Regenerative Medicine, High-Content Screening Assays And Toxicology, Replacement Of Damaged Cells And Others For Sweden - (2009-2015, in USD$ Million)
210. Stem Cells In Drug Discovery Applications - Cell Therapy And Regenerative Medicine, High-Content Screening Assays And Toxicology, Replacement Of Damaged Cells And Others - % Of Swedish Market Value - (2009 - 2012 - 2015)
211. Stem Cells In Drug Discovery Applications - Cell Therapy And Regenerative Medicine, High-Content Screening Assays And Toxicology, Replacement Of Damaged Cells And Others For The United Kingdom - (2009-2015, in USD$ Million)
212. Stem Cells In Drug Discovery Applications - Cell Therapy And Regenerative Medicine, High-Content Screening Assays And Toxicology, Replacement Of Damaged Cells And Others - % Of The United Kingdom Market Value - (2009 - 2012 - 2015)
213. Stem Cells In Drug Discovery Applications - Cell Therapy And Regenerative Medicine, High-Content Screening Assays And Toxicology, Replacement Of Damaged Cells And Others For Rest Of Europe - (2009-2015, in USD$ Million)
214. Stem Cells In Drug Discovery Applications - Cell Therapy And Regenerative Medicine, High-Content Screening Assays And Toxicology, Replacement Of Damaged Cells And Others - % Of Rest Of Europe Market Value - (2009 - 2012 - 2015)

ASIA-PACIFIC

215. Stem Cells In Drug Discovery Applications - Cell Therapy And Regenerative Medicine, High-Content Screening Assays And Toxicology, Replacement Of Damaged Cells And Others For Asia-Pacific - (2009-2015, in USD$ Million)
216. Stem Cells In Drug Discovery Applications - Cell Therapy And Regenerative Medicine, High-Content Screening Assays And Toxicology, Replacement Of Damaged Cells And Others - % Of Asia-Pacific Market Value - (2009 - 2012 - 2015)
217. Stem Cells In Drug Discovery Applications - Cell Therapy And Regenerative Medicine, High-Content Screening Assays And Toxicology, Replacement Of Damaged Cells And Others For Australia - (2009-2015, in USD$ Million)
218. Stem Cells In Drug Discovery Applications - Cell Therapy And Regenerative Medicine, High-Content Screening Assays And Toxicology, Replacement Of Damaged Cells And Others - % Of Australian Market Value - (2009 - 2012 - 2015)
219. Stem Cells In Drug Discovery Applications - Cell Therapy And Regenerative Medicine, High-Content Screening Assays And Toxicology, Replacement Of Damaged Cells And Others For China - (2009-2015, in USD$ Million)
220. Stem Cells In Drug Discovery Applications - Cell Therapy And Regenerative Medicine, High-Content Screening Assays And Toxicology, Replacement Of Damaged Cells And Others - % Of Chinese Market Value - (2009 - 2012 - 2015)
221. Stem Cells In Drug Discovery Applications - Cell Therapy And Regenerative Medicine, High-Content Screening Assays And Toxicology, Replacement Of Damaged Cells And Others For India - (2009-2015, in USD$ Million)
222. Stem Cells In Drug Discovery Applications - Cell Therapy And Regenerative Medicine, High-Content Screening Assays And Toxicology, Replacement Of Damaged Cells And Others - % Of Indian Market Value - (2009 - 2012 - 2015)
223. Stem Cells In Drug Discovery Applications - Cell Therapy And Regenerative Medicine, High-Content Screening Assays And Toxicology, Replacement Of Damaged Cells And Others For Japan - (2009-2015, in USD$ Million)
224. Stem Cells In Drug Discovery Applications - Cell Therapy And Regenerative Medicine, High-Content Screening Assays And Toxicology, Replacement Of Damaged Cells And Others - % Of Japanese Market Value - (2009 - 2012 - 2015)
225. Stem Cells In Drug Discovery Applications - Cell Therapy And Regenerative Medicine, High-Content Screening Assays And Toxicology, Replacement Of Damaged Cells And Others For South Korea - (2009-2015, in USD$ Million)
226. Stem Cells In Drug Discovery Applications - Cell Therapy And Regenerative Medicine, High-Content Screening Assays And Toxicology, Replacement Of Damaged Cells And Others - % Of South Korean Market Value - (2009 - 2012 - 2015)
227. Stem Cells In Drug Discovery Applications - Cell Therapy And Regenerative Medicine, High-Content Screening Assays And Toxicology, Replacement Of Damaged Cells And Others For Rest Of Asia-Pacific - (2009-2015, in USD$ Million)
228. Stem Cells In Drug Discovery Applications - Cell Therapy And Regenerative Medicine, High-Content Screening Assays And Toxicology, Replacement Of Damaged Cells And Others - % Of Rest Of Asia-Pacific Market Value - (2009 - 2012 - 2015)

LATIN AMERICA

229. Stem Cells In Drug Discovery Applications - Cell Therapy And Regenerative Medicine, High-Content Screening Assays And Toxicology, Replacement Of Damaged Cells And Others For Latin America - (2009-2015, in USD$ Million)
230. Stem Cells In Drug Discovery Applications - Cell Therapy And Regenerative Medicine, High-Content Screening Assays And Toxicology, Replacement Of Damaged Cells And Others - % Of Latin America Market Value - (2009 - 2012 - 2015)
231. Stem Cells In Drug Discovery Applications - Cell Therapy And Regenerative Medicine, High-Content Screening Assays And Toxicology, Replacement Of Damaged Cells And Others For Argentina - (2009-2015, in USD$ Million)
232. Stem Cells In Drug Discovery Applications - Cell Therapy And Regenerative Medicine, High-Content Screening Assays And Toxicology, Replacement Of Damaged Cells And Others - % Of Argentina Market Value - (2009 - 2012 - 2015)
233. Stem Cells In Drug Discovery Applications - Cell Therapy And Regenerative Medicine, High-Content Screening Assays And Toxicology, Replacement Of Damaged Cells And Others For Brazil - (2009-2015, in USD$ Million)
234. Stem Cells In Drug Discovery Applications - Cell Therapy And Regenerative Medicine, High-Content Screening Assays And Toxicology, Replacement Of Damaged Cells And Others - % Of Brazilian Market Value - (2009 - 2012 - 2015)

REST OF WORLD

235. Stem Cells In Drug Discovery Applications - Cell Therapy And Regenerative Medicine, High-Content Screening Assays And Toxicology, Replacement Of Damaged Cells And Others For Rest Of World - (2009-2015, in USD$ Million)
236. Stem Cells In Drug Discovery Applications - Cell Therapy And Regenerative Medicine, High-Content Screening Assays And Toxicology, Replacement Of Damaged Cells And Others - % Of Rest Of World Market Value - (2009 - 2012 - 2015)
237. Stem Cells In Drug Discovery Applications - Cell Therapy And Regenerative Medicine, High-Content Screening Assays And Toxicology, Replacement Of Damaged Cells And Others For Columbia - (2009-2015, in USD$ Million)
238. Stem Cells In Drug Discovery Applications - Cell Therapy And Regenerative Medicine, High-Content Screening Assays And Toxicology, Replacement Of Damaged Cells And Others - % Of Columbian Market Value - (2009 - 2012 - 2015)
237. Stem Cells In Drug Discovery Applications - Cell Therapy And Regenerative Medicine, High-Content Screening Assays And Toxicology, Replacement Of Damaged Cells And Others For Middle East - (2009-2015, in USD$ Million)
238. Stem Cells In Drug Discovery Applications - Cell Therapy And Regenerative Medicine, High-Content Screening Assays And Toxicology, Replacement Of Damaged Cells And Others - % Of Middle East Market Value - (2009 - 2012 - 2015)
239. Stem Cells In Drug Discovery Applications - Cell Therapy And Regenerative Medicine, High-Content Screening Assays And Toxicology, Replacement Of Damaged Cells And Others For South Afirica - (2009-2015, in USD$ Million)
240. Stem Cells In Drug Discovery Applications - Cell Therapy And Regenerative Medicine, High-Content Screening Assays And Toxicology, Replacement Of Damaged Cells And Others - % Of South African Market Value - (2009 - 2012 - 2015)
241. Stem Cells In Drug Discovery Applications - Cell Therapy And Regenerative Medicine, High-Content Screening Assays And Toxicology, Replacement Of Damaged Cells And Others For Rest Of Rest Of World - (2009-2015, in USD$ Million)
242. Stem Cells In Drug Discovery Applications - Cell Therapy And Regenerative Medicine, High-Content Screening Assays And Toxicology, Replacement Of Damaged Cells And Others - % Of Rest Of Rest Of World Market Value - (2009 - 2012 - 2015)

G. GROWTH RATE ANALYSIS

GLOBAL STEM CELLS MARKET AND DRUG DISCOVERY APPLICATIONS MARKET GROWTH RATES

243. Global Stem Cells Market Value - % Growth Rate Forecasts - (2009-2015)

STEM CELLS - PRODUCT SEGMENTS

244. Global Stem Cells - Product Segments - % Growth Rate Forecasts - (2009-2015)
245. Global Adult Stem Cells - % Growth Rate Forecasts - (2009-2015)
246. Global Cord Blood Stem Cells - % Growth Rate Forecasts - (2009-2015)
247. Global Embryonic Stem Cells - % Growth Rate Forecasts - (2009-2015)

STEM CELLS IN DRUG DISCOVERY – APPLICATIONS

248. Global Stem Cells In Drug Discovery Applications - % Growth Rate Forecasts - (2009-2015)
249. Global Cell Therapy And Regenerative Medicine - % Growth Rate Forecasts - (2009-2015)
250. Global High-Content Screening Assays And Toxicology - % Growth Rate Forecasts - (2009-2015)
251. Global Replacement Of Damaged Cells - % Growth Rate Forecasts - (2009-2015)

H. INVESTMENT FOCUS

III. INDUSTRY OVERVIEW

252. Stem Cells Companies In Different Countries With Their Year Of Establishment, Accreditation And Stem Cells Banking Storage Price Structure
253. Global List Of Key Companies In Stem Cell Industry

KEY COMPANY PROFILES

Aastrom Biosciences, Inc.
Acorda Therapeutics, Inc.
Advanced Cell Technology, Inc.
Affymetrix, Inc.
Alpha Cord, Inc.
Angioblast Systems, Inc.
Bioheart, Inc.
Cell Therapeutics, Inc.
Corcell, Inc.
Cord Blood Registry
Cryolife, Inc.
Genzyme Corp.
Millipore Corporation
Neostem, Inc.
Osiris Therapeutics, Inc.
Sigma-Aldrich, Co.
Spectrocell, Inc.
Stem Cell Innovations, Inc.
Stem Cells, Inc.
Stemlifeline Sciences, Inc.
Thermo Fisher Scientific, Inc.
Viacell, Inc.
Viacord
Vital Therapies, Inc.
Stem Cells Therapeutics, Corp.
Stemcell Technologies, Inc.
Cells4life, LTD.
GE Healthcare
and many more……………
Skip to top


Ask Your Question

Stem Cells Market And Drug Discovery Applications, 2009-2015
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: